Weekly Analysts’ Ratings Changes for Aveanna Healthcare (AVAH)

Several analysts have recently updated their ratings and price targets for Aveanna Healthcare (NASDAQ: AVAH):

• 8/24/2026 – Aveanna Healthcare had its price target raised by Truist Financial Corporation from $11.00 to $15.00. They now have a “hold” rating on the stock.
• 8/24/2026 – Aveanna Healthcare had its price target raised by Royal Bank Of Canada from $10.00 to $16.00. They now have an “outperform” rating on the stock.
• 8/15/2026 – Aveanna Healthcare was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 8/14/2026 – Aveanna Healthcare had its price target raised by Raymond James Financial, Inc. from $13.00 to $15.00. They now have a “strong-buy” rating on the stock.
• 8/14/2026 – Aveanna Healthcare had its price target raised by UBS Group AG from $8.00 to $13.00. They now have a “neutral” rating on the stock.
• 8/14/2026 – Aveanna Healthcare had its price target raised by BMO Capital Markets from $10.00 to $14.00. They now have an “outperform” rating on the stock.
• 7/14/2026 – Aveanna Healthcare had its price target raised by Truist Financial Corporation from $9.00 to $11.00. They now have a “hold” rating on the stock.
• 7/9/2026 – Aveanna Healthcare had its price target raised by Barclays PLC from $9.00 to $9.50. They now have an “overweight” rating on the stock.
• 7/2/2026 – Aveanna Healthcare had its “hold (c+)” rating reaffirmed by Weiss Ratings.

Insiders Place Their Bets

In related news, major shareholder Robert M. Williams, Jr. sold 2,250,000 shares of the company’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $11.50, for a total value of $25,875,000.00. Following the completion of the transaction, the insider directly owned 12,315,892 shares in the company, valued at approximately $141,632,758. This represents a 15.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Rodney D. Windley sold 180,000 shares of the stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $11.50, for a total value of $2,070,000.00. Following the transaction, the director owned 2,078,017 shares in the company, valued at $23,897,195.50. This trade represents a 7.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 79,746,745 shares of company stock valued at $773,117,091. 5.30% of the stock is currently owned by company insiders.

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.